Healthcare organisations all over the world, and also in Malta, are facing a growing imbalance of supply and demand. They must manage increasing costs while balancing the need to improve access to safe, quality care and services. These cost increases stem from fragmentation of resources, an aging demographic and a shortage of skilled labour. The healthcare system and government must find innovative solutions to provide timely access to quality care, including identifying ways for partnering with the private sector.
Contrasting with this challenging environment, the local pharmaceutical industry is enjoying a period a unprecedented growth, particularly in area of generics manufacture where Malta benefits from favourable patent legislation. Malta’s attractive tax regime is another key driver for the recent flow of foreign direct investment in this sector.
How can PricewaterhouseCoopers help
Healthcare organisations and pharmaceutical companies can benefit from PwC's unique insight and strategies to help address current issues and benefit from emerging opportunities. Our comprehensive range of experience combined with PwC's global network of healthcare professionals allows us to add value in the following key areas:
Tel: +356 2124 7000
Fax: +356 2124 4768
Of further interest
1. Healthcast 2020: Creating a sustainable future
2. Pharma 2020: The vision